Stay updated with breaking news from Needleman Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shripad Bhagwat, a drug development expert with decades of experience in the pharmaceutical and biotech industries, has been named the inaugural senior director of the Needleman Program for Innovation and Commercialization at Washington University in St. Louis.
Carter is a seasoned leader who joins Carolina from Washington University in St. Louis, Missouri, where he serves as vice chancellor and chief commercialization officer and professor of practice in the McKelvey School of Engineering and Olin School of Business
Plus, the University of Michigan landed a $50 million donation for its education school, and three other universities received big gifts.
A $15 million commitment from Washington University benefactors Philip and Sima Needleman will enable the university to leverage its expertise in biomedical discovery to boost drug development via the Needleman Program for Innovation and Commercialization.